Citi analyst Amit Hazan lowered his price target for Intuitive Surgical to $611 from $684 following last week’s “surprise miss” but keeps a Buy rating on the shares. The analyst sees “very solid leading indicators that offer encouragement for longer term fundamentals.” He also believes the recent weakness in the shares present a “compelling buying opportunity.”
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.